| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/01/2004 | CA2509678A1 Immunization of fish with plant-expressed recombinant proteins |
| 07/01/2004 | CA2509583A1 Methods and vectors for making knockout animals |
| 07/01/2004 | CA2509356A1 Glucose and/or fructose transporter naglt1 and its gene |
| 07/01/2004 | CA2509333A1 Method for generating a genetically modified organism for screening active substances |
| 07/01/2004 | CA2507915A1 Recombinant viral-based malaria vaccines |
| 07/01/2004 | CA2506217A1 New expression system from rhodococcus |
| 06/30/2004 | EP1433856A1 Process for producing alcohol with the use of microorganism |
| 06/30/2004 | EP1433855A2 Plasmids suitable for il-2 expression |
| 06/30/2004 | EP1433854A1 Genetically modified plant having an accelerated flowering |
| 06/30/2004 | EP1433853A2 Method for production of S-hydroxynitrile lyase by use of Escherichia coli |
| 06/30/2004 | EP1433852A1 Lipase and use of same for improving doughs and baked products |
| 06/30/2004 | EP1433851A2 Improved expression of HIV polypeptides and production of virus-like particles |
| 06/30/2004 | EP1433850A1 Control of plant flowering time by regulating the expression of phytochrome c |
| 06/30/2004 | EP1433849A1 NOVEL POLYPEPTIDE, DNA THEREOF AND USE OF THE SAME |
| 06/30/2004 | EP1433848A1 Novel serine protease inhibitory protein mt0039 |
| 06/30/2004 | EP1433847A1 Method of interfering with gene expression in mammalian post-implantation embryos |
| 06/30/2004 | EP1433846A2 Phagemid-based method of producing filamentous bacteriophage particles displaying antibody molecules and the corresponding bacteriophage particles. |
| 06/30/2004 | EP1433845A1 Clostridium tetani collagenase and uses thereof |
| 06/30/2004 | EP1433844A2 Novel recombinant xylanases derived from anaerobic fungi, and the relevant sequences, expression vectors and hosts |
| 06/30/2004 | EP1433842A1 Recombinant bovine pancreatic desoxyribonuclease I with high specific activity |
| 06/30/2004 | EP1433841A1 Method for low-temperature culture of microorganism |
| 06/30/2004 | EP1433792A2 Human receptor proteins, related reagents and methods |
| 06/30/2004 | EP1433791A2 Process for producing dipeptides |
| 06/30/2004 | EP1433483A1 Reovirus for the treatment of neoplasia wherein double stranded RNA-activated protein kinase (PKR) is inactivated or deleted |
| 06/30/2004 | EP1432989A1 Randomly ordered arrays and methods of making and using |
| 06/30/2004 | EP1432983A1 Method for identifying polymorphic markers in a population |
| 06/30/2004 | EP1432980A2 Protein design automation for protein libraries |
| 06/30/2004 | EP1432832A2 Detection and quantification of human herpes viruses |
| 06/30/2004 | EP1432831A2 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays |
| 06/30/2004 | EP1432830A1 Method for isolating dna from biological samples |
| 06/30/2004 | EP1432826A2 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 06/30/2004 | EP1432824A2 Compositions and methods relating to prostate specific genes and proteins |
| 06/30/2004 | EP1432823A2 Mitochondrial biology expression arrays |
| 06/30/2004 | EP1432819A2 Method for determining cell cycle position |
| 06/30/2004 | EP1432818A1 Nucleic acid archiving |
| 06/30/2004 | EP1432816A2 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances |
| 06/30/2004 | EP1432814A2 Antimicrobial methods and materials |
| 06/30/2004 | EP1432810A2 Production of recombinant proteins in vivo and use for generating antibodies |
| 06/30/2004 | EP1432808A2 Regulation of translation of heterologously expressed genes |
| 06/30/2004 | EP1432807A2 Induction of gene expression by silencing of repressor genes |
| 06/30/2004 | EP1432806A2 A repressor-mediated regulation system for control of gene expression in plants |
| 06/30/2004 | EP1432805A2 Dna-expression construct for treatment of infections with leishmaniasis |
| 06/30/2004 | EP1432804A2 Compositions and methods relating to ovary specific genes and proteins |
| 06/30/2004 | EP1432803A2 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
| 06/30/2004 | EP1432802A2 Pegylated and diglycosylated erythropoietin |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |
| 06/30/2004 | EP1432799A2 Silencing of gene expression by sirna |
| 06/30/2004 | EP1432798A2 Self-processing plants and plant parts |
| 06/30/2004 | EP1432797A2 Methods for dna manipulation |
| 06/30/2004 | EP1432796A1 Stable episomal vectors |
| 06/30/2004 | EP1432794A2 Human coagulation factor vii polypeptides |
| 06/30/2004 | EP1432793A2 Aminopeptidase |
| 06/30/2004 | EP1432792A2 Histone deacetylase 9 |
| 06/30/2004 | EP1432791A1 Alphavirus replicon vector systems |
| 06/30/2004 | EP1432737A2 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |
| 06/30/2004 | EP1432736A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 06/30/2004 | EP1432735A2 Antagonistic anti-htnfsf13b human antibodies |
| 06/30/2004 | EP1432732A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432725A1 RNA INTERFERENCE MEDIATED INHIBITION OF TELOMERASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/30/2004 | EP1432724A1 Rna interference mediated inhibition of map kinase genes |
| 06/30/2004 | EP1432723A2 Modulation of the expression of genes dependent on stat-1 |
| 06/30/2004 | EP1432722A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/30/2004 | EP1432527A2 Biological control of nanoparticles |
| 06/30/2004 | EP1432452A2 Inhibition of stat-1 |
| 06/30/2004 | EP1432451A2 Production of fusion proteins and use for identifying binding molecules |
| 06/30/2004 | EP1432448A2 Novel molecules of the hkid-1-related protein family and uses thereof |
| 06/30/2004 | EP1432444A2 Anti-a-beta antibodies |
| 06/30/2004 | EP1432443A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 06/30/2004 | EP1432441A2 Use of hmgb1 for the activation of dendritic cells |
| 06/30/2004 | EP1432439A2 Means for improving immune response |
| 06/30/2004 | EP1432438A2 Use of rank antagonists to treat cancer |
| 06/30/2004 | EP1432433A2 Antagonists |
| 06/30/2004 | EP1432431A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 06/30/2004 | EP1390545A4 Biological sample processing methods and compositions that include surfactants |
| 06/30/2004 | EP1383372A4 Bioluminescent plants and methods of making same |
| 06/30/2004 | EP1366197A4 Methods and compositions for amplification of rna sequences |
| 06/30/2004 | EP1317569A4 Microfluidic devices and methods for performing temperature mediated reactions |
| 06/30/2004 | EP1313543A4 Device and methods for subdividing and filtering gel material and extracting molecules therefrom |
| 06/30/2004 | EP1235919B1 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 06/30/2004 | EP1231831A4 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 06/30/2004 | EP1230398B1 Colour labelled oligonucleotide for labelling a nucleic acid molecule |
| 06/30/2004 | EP1169063B1 Treatment of intracellular infection |
| 06/30/2004 | EP1127161A4 Method for making complementary oligonucleotide tag sets |
| 06/30/2004 | EP1112366B1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 06/30/2004 | EP1072688B1 Method for in vivo detecting a target protein gene by a drug |
| 06/30/2004 | EP1054688B1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses |
| 06/30/2004 | EP1032418B1 Compact epstein-barr virus replicons |
| 06/30/2004 | EP1021554A4 Analyte assay using particulate labels |
| 06/30/2004 | EP1012339A4 Method for determining propensity for developing late-onset alzheimer's disease |
| 06/30/2004 | EP1007712A4 The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
| 06/30/2004 | EP1007637B1 Methods for increasing the efficiency of recombinant aav product |
| 06/30/2004 | EP0977988A4 Homogeneous fluorescence assay for measuring the effect of compounds on gene expression |
| 06/30/2004 | EP0977600B1 Contrast agents targetting receptors associated with angiogenesis |
| 06/30/2004 | EP0954584B1 Methods for improving transformation efficiency |
| 06/30/2004 | EP0943012A4 Identification of molecular sequence signatures and methods involving the same |
| 06/30/2004 | EP0925554B1 Method and computer program for analyzing images |
| 06/30/2004 | EP0915902A4 Transgenic animals expressing artificial epitope-tagged proteins |
| 06/30/2004 | EP0914419B1 Transgenic mice capable of expressing leukemia inhibitory factor |
| 06/30/2004 | EP0906437B1 Process for the production of plants with enhanced growth characteristics |